Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal)

  • Technology appraisal
  • TA966
  • Published: 

History

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators